Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction

Mise à jour : Il y a 4 ans
Référence : NCT01492218

Femme et Homme

  • | Pays :
  • Philippines
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This study is conducted in Asia. The aim of this study is to assess patient satisfaction after switching to biphasic human insulin 30 treatment using the NovoLet® insulin device as treatment for diabetes mellitus under normal clinical practice setting.


Critère d'inclusion

  • diabetes ,Diabetes Mellitus, Type 1 ,Diabetes Mellitus, Type 2

Liens